What is in your herbal medicine?

In focus / 25 June 2020

Photo: Paulius Dragunas, Unsplash

Journey into the jungle with the Drug Safety Matters podcast to explore the wild and fascinating world of working safely with herbal medicines.


Herbal substances can be found in a number of pharmaceutical drugs, cosmetics and food supplements – so it's not surprising that using plant names inconsistently can have serious health consequences. But with so much confusion around medicinal plant names, it’s easy to get it wrong.

In the latest epsiode of UMC’s Drug Safety Matters podcast, host Federica Santoro speaks to Bob Allkin from the UK’s Royal Botanic Gardens, Kew to try to clear a path through the undergrowth. Fede and Bob discuss how common, scientific and pharmaceutical plant names differ; how Kew’s Medicinal Plant Names Service works, and the ways in which healthcare and pharmacovigilance professionals can avoid mistakes when working with herbal medicines.

You can subscribe to Drug Safety Matters through your favourite podcast player, or listen on the web here.

Kew Gardens' Bob Allkin joins Federica Santoro in the studio for the Drug Safety Matters podcast. Photo: UMC

Kew Gardens' Bob Allkin joins Federica Santoro in the studio for the Drug Safety Matters podcast. Photo: UMC

Read more:

Bob Allkin's work was also featured in an earlier Uppsala Reports article, Navigating the plant-names jungle.

Tags: podcast, botanicals, HerbalMedicines, TraditionalMedicines

You may also like


Interesting times indeed for Europe’s top medicines regulator

There was no chance the new head of the European Union’s medicines regulator could simply ease into the job. Emer Cooke, had Brexit and a pandemic on her desk from day one.

In focus / 21 January 2021

Improving medication safety for children: The KIDs List

Some medicines are inappropriate for children, while others require special consideration or monitoring. The KIDS List is a valuable new resource to guide paediatric prescribing.

In focus / 11 December 2020

Substandard and Falsified COVID-19 Vaccines in the Americas: Can vaccine equity help?

COVID-19 vaccinations are picking up speed in wealthy countries. But for lower-income countries, does poor equity of access raise the risk of compromised products?

In focus / 07 May 2021

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more